{"url_path":"/sec/lixt/8-k/2026-06-04/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 Entry Into a Material Definitive Agreement","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1335105/0001493152-26-027307-index.html","accession_number":"0001493152-26-027307","cik":"0001335105","ticker":"LIXT","issuer_name":"NOMAD POWER SOLUTIONS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1335105/0001493152-26-027307-index.html","primary_entity_key":"0001335105","primary_entity_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC."},"word_count":377,"has_tables":true,"body_markdown":"Item\n1.01. Entry Into a Material Definitive Agreement\n\n** **\n\nOn\nJune 2, 2026, Lixte Biotechnology Holdings, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase\nAgreement (the “Purchase Agreement”) with certain accredited investors named therein (the “Purchasers”), pursuant\nto which the Company agreed to issue and sell, in a registered direct offering (the “Offering”), 2,366,503 shares (the “Common\nShares”) of the Company’s Common Stock, par value $0.0001 per share (the “Common Stock”), and Pre-Funded Warrants\n(“Pre-Funded Warrants”) to purchase 258,859 shares of Common Stock, at an offering price of $6.31 per share (or $6.30 per\nPre-Funded Warrant). The Pre-Funded Warrants are exercisable immediately, at an exercise price of $0.0001 per share, and may be exercised\nat any time until all of the Pre-Funded Warrants are exercised in full.\n\n \n\nThe\nOffering resulted in gross proceeds of approximately $16.6 million before deducting offering expenses. The Offering closed on June 4,\n2026.\n\n \n\nThe\nOffering was made pursuant to the Company’s existing shelf registration statement on Form S-3 (File No. 333-278874) (the “Registration\nStatement”), which was declared effective on May 2, 2024 by the U.S. Securities and Exchange Commission (the “Commission”),\nthe base prospectus filed as part of the Registration Statement, and the prospectus supplement dated June 4, 2026. The Registration\nStatement, the base prospectus and the prospectus supplement are available on the SEC’s website at www.sec.gov. \n\n \n\nThe\nforegoing summaries of the Pre-Funded Warrants and Purchase Agreement do not purport to be complete and are subject to and qualified\nin their entirety by such documents attached as Exhibit 4.1 and Exhibit 10.1, respectively, to this Current Report on Form 8-K, and which are\nincorporated herein in their entirety by reference.\n\n \n\nThe\nCompany is filing the opinion of its counsel, Sichenzia Ross Ference Carmel LLP, relating to the legality of the issuance and sale of\nthe Common Shares and Pre-Funded Warrants as Exhibit 4.1 hereto and incorporated by reference.\n\n \n\nThis\nForm 8-K does not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, nor shall there be\nany sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration\nor qualification under the securities laws of any such state or jurisdiction."}